Companies / RHT

RESONANCE HEALTH LIMITED

ASX:RHTHealth Care Equipment & Services
477.1M shares on issueASX (delayed) · as of 28 July 2026$0.052price · delayed$24.8Mmarket cap · indicative
A
Dilution grade

No major dilution pressure signals in current disclosures

Cash runway37.1 quarters of funding
Share-count growth (24m)3.8%
Raise cadence (24m)0 cash raises
Options & rights overhang2.1% of shares
In-the-money supply0.0% of shares
Pending proposed issuesnone

RESONANCE HEALTH LIMITED's ordinary share count was 477M as of March 2026, up 3.8% since November 2024. The company did not raise capital in the most recent 24‑month window. Options and rights on issue could convert into 10M new shares, equal to 2.1% of the current share count, with 0% in the money and the nearest expiry in June 2029. At the June 2026 quarter the company reported A$5.1M in available cash, representing 37.1 quarters of cash cover at its reported burn. No proposed securities issues (Appendix 3B) are currently pending.

AI-generated summary of this page's cited filings · updated 28 July 2026
Email me when this grade changes
Alerts are coming soon — this opens a pre-filled email that puts you on the list.
2.1%
Max option dilution
0.0%
ITM option dilution
0
Raises · last 12 months
37.1 qtrs
Cash cover · over 4 quarters

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 477.1M per ASX (delayed) (28 July 2026).
463.3M468.4M473.4MDec 24Sept 25July 26

Cash runway

—
Cover not computed for the latest quarter.
$5.1M available cash at quarter ended 30 June 2026 · Runway is computed from Appendix 4C/5B filings and announced raise proceeds.
Paid plan
Cash runway history
Quarterly cash, net spend and cover trend from every Appendix 4C/5B on record up to 30 June 2026.
Join the waitlist

Issuance timeline

Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityTotal on issue afterSource
1 Mar 20262A · quoted issueRHT : ORDINARY FULLY PAID477.1MAppendix 2A
27 Feb 20263G · unquotedRHT : ORDINARY FULLY PAID474.8MAppendix 3G
14 Dec 20252A · quoted issueRHT : ORDINARY FULLY PAID474.8MAppendix 2A
28 Oct 20252A · quoted issueRHT : ORDINARY FULLY PAID474.5MAppendix 2A
28 Oct 20253H · cancellationRHT : ORDINARY FULLY PAID470.8MAppendix 3H
Paid plan
Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Join the waitlist

Capital raises

No equity raises in the last 24 months.
Paid plan
Full raise history
Issue price, discount, brokers, purpose and tranche detail for every raise on record.
Join the waitlist

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

2.1%
Total overhang · of current shares
0.0%
In the money · at current price
10.0M
Potential new shares
June 2029
Nearest expiry
Paid plan
Per-line options & expiry cliffs
Each option line — code, strike, expiry, quantity and ITM value — plus the expiry-cliff chart.
Join the waitlist

Director dealings

DateDirectorTypeSharesOptionsValueSource
13 July 2026Simon PantonBuy1.6M—$74k3Y notice
22 May 2026David FullerBuy99k—$4k3Y notice
27 Mar 2026Simon PantonBuy2.6M—$106k3Y notice
Paid plan
Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Join the waitlist

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Sign up free — coming soon

Latest announcements

23 July 2026$PQuarterly Activities/Appendix 4C Cash Flow Report
15 July 2026Change of Director's Interest Notice - Simon Panton
8 June 2026$PLiver Fibrosis Device Progress & FY26 Portfolio Webinar
26 May 2026Change of Director's Interest Notice - Dr David Fuller
4 May 2026$PProfit Guidance Upgrade
28 Apr 2026$PQuarterly Activities/Appendix 4C Cash Flow Report
27 Apr 2026Initial Director's Interest Notice - Michael Sistenich
27 Apr 2026Initial Director's Interest Notice - Dr David Fuller
27 Apr 2026Director Appointments
31 Mar 2026Change of Director's Interest Notice - Simon Panton
16 Mar 2026$PReceipt of R&D Tax Incentive Refund
1 Mar 2026Application for quotation of securities - RHT
27 Feb 2026Notification regarding unquoted securities - RHT
26 Feb 2026$PHalf Year Results Presentation
26 Feb 2026$PHalf Year Results
26 Feb 2026$PHalf Year Report & Accounts
29 Jan 2026$PQuarterly Activities/Appendix 4C Cash Flow Report
14 Dec 2025Change of Director's Interest Notice - Simon Panton
14 Dec 2025Application for quotation of securities - RHT
1 Dec 2025Change of Director's Interest Notice - Simon Panton

Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 July 2026.